Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone

Hormone Research in Paediatrics

Volumn 39, Issue 5-6, 1993, Pages 229-234

  Ohzeki, Takehiko ^a   Hanaki, Keiichi ^a   Motozumi, Hiroko ^a   Ohtahara, Hiroko ^a   Ishitani, Nobuo ^a   Urashima, Hirofumi ^a   Tsukuda, Toshinori ^a   Shiraki, Kazuo ^a   Sasaki, Shigekazu ^b   Nakamura, Hirotoshi ^b   Imura, Hiroo ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bromocriptine; Hyperthyroidism; Pituitary; Thyroid hormone receptor; Thyroid stimulating hormone; Thyroxine; Triiodothyronine

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONE RESISTANCE; HUMAN; HYPOPHYSIS FUNCTION; LIOTHYRONINE BLOOD LEVEL; PRIORITY JOURNAL; SCHOOL CHILD; THYROTROPIN BLOOD LEVEL;

BROMOCRIPTINE; CASE REPORT; CHILD; DRUG RESISTANCE; FEMALE; HUMAN; HYPERTHYROIDISM; PITUITARY GLAND; THYROID HORMONES; THYROTROPIN; TRIIODOTHYRONINE;

EID: 0027360316     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000182741     Document Type: Article

References (26)

1. Refetoff SLT, DeWind LT, DeGroot U: Familial syndrome combining deaf mutism, stippled epiphyses, goiter and abnormally high PBI: Possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967; 27: 279-294.
2. McKusick VA: Thyroid hormone unresponsiveness (Refetoff syndrome; resistance to thyroid hormone); Mendelian Inheritance in Man. Baltimore, Johns Hopkins University Press, 1988, pp 1209-1210.
3. Gcrshengorn MC, Weintraub BD: Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. J Clin Invest 1975; 56: 633-642.
4. Sakurai T, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ: Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci USA 1989; 86: 8977-8981.
5. Usala SJ, Menke JB, Watson TL, Wondisford FE, Weintraub BD, Berard J, Bradley WEC, Ono S, Mueller OT, Bercu BB: A homozygous deletion in the c-erbAbeta thyroid hormone receptor gene in a patient with generalized thyroid resistance: Isolation and characterization of the mutant receptor. Mol Endocrinol 1991; 5: 327-335.
6. Sasaki S, Nakamura H, Tagami T, Miyoshi Y, Tanaka K, Intura H: A point mutation of the T3 receptor beta 1 gene in a kindred of generalized resistance to thyroid hormone. Mol Cell Endocrinol 1992; 84: 159-166.
7. Ohzeki T, Egi S, Egawa M, Hachimori K: Thyroid hormone unresponsiveness in two siblings with intrauterine growth retardation and exophthalmos. Eur J Pediatr 1984; 141: 181-183.
8. Harmon P, Bovier-Lapierre M, Robert M, Peynaud D, Pugeat M, Orgiazzi J: Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: Efficacy of D-thyroxine therapy. J Clin Endocrinol Metab 1988; 67: 1089-1093.
9. Roesler A, Litvin Y, Hage C, Gross J, Cerasi E: Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine. J Clin Endocrinol Metab 1982; 54: 76-82.
10. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G: Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3, 5, 3′-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 1983; 6: 217-223.
11. Salmela PL Wide L, Juustila H, Ruokonen A: Effects of thyroid hormones (T4, T3), bromocriptine and TRIAC on inappropriate TSH hypersecretion. Clin Endocrinol 1988; 28: 497-507.
12. Williams G, Kraenzlin M, Sandler L, Burrin J, Law A, Bloom S, Joplin GF: Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995). Acta Endocrinol (Copenh) 1986; 113: 42-46.
13. Beck-Peccoz P, Mariotti S, Guillausseau PJ, Medri G, Piscitelli G, Bertoli A, Barbarino A, Rondena M, Chanson Ph, Pinchera A, Faglia G: Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab 1989; 68: 208-214.
14. Sriwatanakul K, McCormic K, Woolf P: Thyrotropin (TSH)-induced hyperthyroidism: Response of TSH to dopamine and its agonists. J Clin Endocrinol Metab 1984; 58: 255-261.
15. Takamatsu J, Mozai T, Kuma K: Bromocriptine therapy for hyperthyroidism due to increased thyrotropin secretion. J Clin Endocrinol Metab 1984; 58: 934-936.
16. Faglia G, Beck-Peccoz P, Medri G: Inappropriate secretion of thyrotropin by the pituitary. Horm Res 1987; 26: 79-99.
17. Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M, Hershman JM: 3, 5, 3′-Triiodothyroacctic acid therapy for thyroid hormone resistance. J Clin Endocrinol Metab 1989; 69: 461-466.
18. Takamatsu J, Majima M, Miki K, Kuma K, Mozai T: Serum ferritin as a marker of thyroid hormone action on peripheral tissues. J Clin Endocrinol Metab 1985; 61: 672-676.
19. Ohzeki T, Hanaki K, Motozumi H, Matsuda-Ohtahara H, Ishitani N, Shiraki K: Refractoriness at peripheral and pituitary receptors in general and pituitary types of thyroid hormone resistance. Horm Metab Res 1992; 24: 484-487.
20. Same DM, Refet off S, Rosenfield RL, Farriaux JP: Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: The value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab 1988; 66: 740-746.
21. Connell JMC, McCruden DC, Davies DL, Alexander WD: Bromocriptine for inappropriate thyrotropin secretion. Ann Intern Med 1982; 96: 251-252.
22. Cooper DS, Ladcnson PW, Nisula BC, Dunn JF, Chapman EM, Ridgway EC: Familial thyroid hormone resistance. Metabolism 1982; 31: 504-509.
23. Bajorunas DR, Rosner W, Kourides IA: Use of bromocriptine in a patient with generalized resistance to thyroid hormone. J Clin Endocrinol Metab 1984; 58: 731-735.
24. Besses GS, Burrow GN, Spaulding SW, Donabedian RK: Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J Clin Endocrinol Metab 1975; 41: 985-987.
25. Magee B, Sheridan B, Scanlon MF, Atkinson AB: Inappropriate thyrotropin secretion, increased dopaminergic tone and preservation of the diurnal rhythm in serum TSH. Clin Endocrinol 1986; 24: 209-215.
26. Vekemans M, Robyn C: Influence of age on scrum prolactin levels in women and men. Br Med J 1975; 4: 738-739.